R&D How a century-old technology could revolutionise LNP charact... The utility of AUC in LNP characterisation is growing, thanks to ongoing efforts to improve the technology.
R&D Staying on course: How hybrid FSP/FSO models are shaping cli... Biotech and pharma companies increasingly require additional agility, flexibility, and operational efficiency in their clinical research operations.
R&D Bolstering CAR-T therapies by tackling CRS, with Teresa Whal... In interview with Teresa Whalen, the CEO of CytoAgents, a clinical-stage drug development company working on a treatment for cytokine release syndrome
R&D Allosteric small molecule therapies in PD, with Gene Mack pharmaphorum looks back to a conversation with Gain Therapeutics' CEO Gene Mack earlier in the year, on research in the Parkinson's disease space.
R&D From pilots to patients: Why the UK must rethink NHS innovat... At PharmaTech Integrates in Glasgow, speakers from government, academia, the NHS, and pharma sought to define the sector’s path forward.
News Roche launches liver disease algorithm panel Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with chronic liver disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
